biomedical News
-
Showcase
Corify Care Participates In the Atrial Signals Workshop 2021
Last week (23-25th September) took place the workshop Atrial Signals 2021 http://www.atrial-signals.kit.edu/ at the Karlsruhe Institute of Technology (KIT), thanks to the joint collaboration of the Institute of Biomedical Engineering (IBT) and the Städtisches Klinikum Karlsruhe. Andreu Climent, CEO of Corify Care presented Acorys, our Non-invasive Electrocardiographic Imaging device of the ...
-
Showcase
RTsafe and Biomedic Medical Group sign exclusive agreement for distribution
RTsafe, a medical technology company focused on improving the safety and accuracy of radiotherapy for cancer and other medical conditions, today announced that Biomedic Medical Group will be the exclusive distributor of RTsafe’s products in China. We are delighted to announce this new collaboration and looking forward to provide our products to the Chinese radiotherapy professionals. ...
By RTsafe
-
Beeken Biomedical Receives FDA Class II Clearance for Temporary Internal Use
Beeken Biomedical recently received FDA Class II Clearance for Temporary Internal Use on the NuStat Hospital Product Line. You can view the letter and summary here. ...
-
ABK Biomedical Inc. Raises $30M USD in Series B Financing
ABK Biomedical, Inc., a medical device company dedicated to the research, development and commercialization of innovative embolic therapies, announced a $30 million USD Series B financing. The round is co-led by F-Prime Capital and Varian Medical Systems. ABK Biomedical will use the funding for continued focused product development of its Eye90 microspheres™, which are designed for ...
-
Bened Biomedical Affiliates US Distributor, Now Bened Life
Bened Biomedical Co, LTD., the global leader in psychobiotics with clinical studies, has acquired its US distributor Oryx Biomedical, Inc., who is pioneering the translation of microbiome research into impactful biotherapeutics and is one of the earliest stage companies bringing the gut-brain axis category of probiotics to the market. Based in Taiwan and founded by Prof. Ying-Chieh Tsai, PhD, ...
-
Centerline Biomedical presentation from LSI 2021: Emerging MedTech Summit
We are excited to share our full presentation from LSI 2021! We are incredibly proud of our IOPS technology and the impact it is having on procedural quality, safety, and efficiency for patients, caregivers, and staff. Centerline Biomedical presenting at LSI 2021: Emerging MedTech ...
-
ACOA Anounces $3M in Support to ABK for Easi-Vue Embolization Microspheres
ABK Biomedical received support from the Atlantic Canada Opportunities Agency (ACOA) to commercialize its Easi-Vue embolization microspheres in-house. The successful commercialization of this innovation will lead to new business opportunities and more well-paying jobs as the microspheres are set to compete in global markets. The funding was announced in February 2018 at ABK’s new facility ...
-
Microneedle patch technology shows potential for long-acting contraception
ATLANTA, January 14, 2019 – The laboratory of Prof. Mark Prausnitz at Georgia Tech developed dissolving microneedle patches that administer a long-acting contraceptive for more than 30 days using microneedle technology licensed exclusively to Micron Biomedical. This work was published in the journal Nature Biomedical Engineering on January 14, 2019. In the study conducted in animals, ...
-
Phase One Development Of Rapid Covid-19 Point Of Care Test Complete
Pepex Biomedical has effectively concluded first stage development efforts including successfully demonstrating working chemistry and manufacturing functionality of its existing electrochemical biosensor. ...
-
Centerline Biomedical selected as a 2020 TechConnect Defense Innovation Awardee
The annual TechConnect Defense Innovation Awards recognizes the top 15% of submitted Challenge technologies as ranked by the Selection Committee. To see the full list of awardees, visit https://events.techconnect.org/DTCFall/awards.html Centerline Biomedical will be featured during the “Biotech/Medical II: Innovation Spotlights” session in the upcoming Virtual Defense TechConnect ...
-
Symberix Receives Additional Carolina Kickstart Award from the North Carolina Translational and Clinical Sciences Institute at UNC-Chapel Hill
Symberix received a second $28,000 Carolina Kickstart award from the North Carolina Translational and Clinical Sciences (NC TraCS) Institute at The University of North Carolina at Chapel Hill. This program provides support for researchers commercializing biomedical technologies through startup generation by supporting company launch through coaching and mentoring, providing over early-stage ...
-
The Florida Chapter, American College of Surgeons, and Reprise Biomedical are pleased to host a FREE Webinar
The Florida Chapter, American College of Surgeons, and Reprise Biomedical are pleased to host a FREE Webinar on Tuesday, January 19th, 2021 at 7:00 p.m. EST. ???? Join us for a 45 min presentation followed by a Q&A session on “Reducing Failure Rates in Hiatal and Paraesophageal Hernia Repair – the ‘Achilles Heel’ of Anti-reflux Surgery” with Dr. G. Kevin Gillian. ...
-
Clearside Biomedical to Present at the Ophthalmology Futures Retina Forum 2022
Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today that Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer will present a company overview and participate in an industry panel virtually during the Ophthalmology Futures ...
-
Pixee Medical is proud to extend its business in the UK
Pixee Medical is proud to extend its business in the UK! We are now ready to perform the first surgeries soon in the Great Britain and Ireland with our distributors. An opportunity to highlight two people involved in this project with Lucie Pécheur, in charge of the regulatory aspects and Cécile IMBERT our Operations Director to manage the commercial launch. Both are graduates of ...
-
Synergy Biomedical Announces Publication of Core Scientific Study on Its BioSphere® Bone Graft Technology
Synergy Biomedical, LLC, a developer of innovative bone graft products for spine and orthopedic surgery, announced the publication of a basic science study describing the findings and scientific strategies of controlling the bone formation response of bioactive glass. This study was conducted by Synergy’s founder, Mark Borden Ph.D. and a team of clinical and basic science collaborators, and ...
-
Innovating Biomedical Engineering: Installation at the University of Strathclyde
Stephen Haywood, Test and Installation Engineer at Hiden Analytical, recently installed an EQP Mass and Energy Analyser at the University of Strathclyde’s Biomedical Engineering Department. This revolutionary tool will accelerate their research on prosthetic ...
-
Aesther Healthcare Acquisition Corp. Announces Payment of Fee to Extend Period to Consummate Business Combination
New York, NY and Providence, RI, Sept. 19, 2022 (GLOBE NEWSWIRE) -- As previously announced, on August 31, 2022, Aesther Healthcare Acquisition Corp. (“Aesther”) (NASDAQ: AEHA) entered into definitive merger agreement with Ocean Biomedical, Inc. Aesther announced today that it has paid, and that Continental Stock Transfer & Trust Company has received, $1,050,000 from Aesther ...
-
Pepex Announces New Rapid Covid-19 Point Of Care Test
Pepex Biomedical has diverted funds and resources to the development of Multiple Rapid Covid-19 Tests designed to accurately identify Antigens (diagnostic to detect active virus) and Antibodies (to determine immunity) in under 15 minutes with 95% accuracy ...
-
Aesther Healthcare (AEHA) Announces $75M Share Purchase Agreement for Ocean Biomedical Deal
Aesther Healthcare (NASDAQ:AEHA) announced this morning that it has inked a common stock purchase agreement with White Lion Capital that will provide up to $75 million to its combination target Ocean Biomedical. Following close, Ocean may direct White Lion to purchase shares in the company worth up to $2 million or 67% of the five-day average daily trading volume. White Lion previously signed an ...
-
Bexson Biomedical Announces Participation in the Jeffries Innovation in Mental Health Summit
Bexson Biomedical, Inc., a biopharmaceutical company focused on disrupting the $189 billion small molecule injectable market and enabling home health solutions, today announced that the Company’s management will be participating in the 2022 Jeffries Innovation inMental Health Summit. Bexson’s Chief Executive Officer, Gregg Peterson, and Chief Scientific Officer, Jeffrey Becker, are ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you